Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis
A Phase III, Randomized Multi-centre, Double-blind, Parallel Group, Active Comparator Study to Compare the Efficacy and Safety of SPD476 (Mesalazine)2.4g/Day Once Daily With Asacol 1.6g/Day Twice Daily in the Maintenance of Remission in Patients With Ulcerative Colitis
2 other identifiers
interventional
829
28 countries
142
Brief Summary
Ulcerative colitis is a disease of the large bowel (colon) and rectum in which the lining of the bowel becomes red and swollen. Over time, patients with this disease may experience acute episodes of diarrhea, rectal bleeding and abdominal pain followed by periods of time without disease symptoms. 5-ASA drugs are a standard treatment for ulcerative colitis. Mesalazine is an experimental drug designed to gradually release 5-ASA into the areas of large bowel associated with ulcerative colitis. This study will test the safety and efficacy of mesalazine in keeping ulcerative colitis in remission.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Apr 2005
Typical duration for phase_3
142 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 8, 2005
CompletedFirst Submitted
Initial submission to the registry
September 7, 2005
CompletedFirst Posted
Study publicly available on registry
September 9, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 7, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
September 7, 2009
CompletedResults Posted
Study results publicly available
September 21, 2010
CompletedJune 14, 2021
June 1, 2021
4.4 years
September 7, 2005
August 26, 2010
June 8, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Endoscopic Remission of Ulcerative Colitis (UC) at 6 Months
Endoscopic remission is defined as an endoscopy score of less than or equal to 1. Endoscopy score (mucosal appearance) ranges from 0-3 (0 = normal \[intact vascular pattern; no friability or granulation\], 1 = mild \[erythema; decreased vascular pattern; minimal granularity\], 2 = moderate \[marked erythema; granularity; friability; absent vascular pattern; bleeding with minimal trauma; no ulcerations\], 3 = severe \[ulceration; spontaneous bleeding\].
6 Months
Secondary Outcomes (4)
Withdrawal Due to Relapse of UC
Over 6 Months
Endoscopic Remission of UC With No or Mild Symptoms at 6 Months
6 Months
Change From Baseline in Modified Ulcerative Colitis Disease Activity Index (UCDAI) Score at 6 Months
Baseline and 6 months
Short Inflammatory Bowel Disease Questionnaire (SIBDQ) Total Score
6 Months
Study Arms (2)
SPD476
EXPERIMENTALMesalazine
Asacol
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- previous diagnosis of ulcerative colitis confirmed by histology that has been considered to be in remission for =\> 30 days
- female subjects must be post-menopausal, surgically or biologically sterile, or with a negative urine pregnancy test at screening and on adequate contraception
You may not qualify if:
- proctitis
- previous resective colonic surgery
- Crohn's disease
- hypersensitivity to salicylates
- moderate/severe renal impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shirelead
Study Sites (142)
Birmingham Gastroenterology Associates
Birmingham, Alabama, 35209, United States
Connecticut Gastroenterology Institute
Bristol, Connecticut, 06010, United States
Washington Gastroenterology
Washington D.C., District of Columbia, 20010, United States
Southern Clinical Research Consultants
Hollywood, Florida, 33021, United States
Boorland-Groover Clinic
Jacksonville, Florida, 32256, United States
United Medical Research
New Smyrna Beach, Florida, 32168, United States
Atlanta Gastroenterology Associates
Atlanta, Georgia, 30342, United States
Midwest Clinical Research Center
Moline, Illinois, 61265, United States
Gastrointestinal Clinic of Quad Cities
Davenport, Iowa, 52807, United States
Drug Research Services, Inc.
Metairie, Louisiana, 70006, United States
Mayo Clinic
Rochester, Minnesota, 55905, United States
Center for Digestive and Liver Diseases, Inc
Mexico, Missouri, 65265, United States
New York Center for Clinical Research
Lake Success, New York, 11042, United States
ClinSearch
Chattanooga, Tennessee, 37404, United States
S D Khan
Houston, Texas, 77090, United States
Hospital Italiano de Buenos Aires
Capital Federal, Buenos Aires, C1181ACH, Argentina
Centro Integral De Gastroenterologia
Ciudad de Buenos Aires, C1425EUG, Argentina
Hospital Italiano de Mendoza, FINAMED SA
Mendoza, M5519GLU, Argentina
Bankstown-Lidcombe Hospital
Bankstown, New South Wales, 2200, Australia
Concord Hospital
Concord, New South Wales, 2139, Australia
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
Eastern Health Hospital
Box Hill, Victoria, 3128, Australia
St Vincent's Hospital
Fitzroy, Victoria, 3065, Australia
Fremantle Hospital
Fremantle, Western Australia, 6160, Australia
Imelda General Hospital
Bonheiden, 2820, Belgium
Ziekenhuis Oost Limburg
Genk, 3600, Belgium
Heilig Hart ziekenhuis vzw Roeselare-Menen
Roeselare, 8800, Belgium
Unigastro
Castelo, 13070-040, Brazil
Hospital de Clinicas
Porto Alegre, Brazil
Universidade Federal do Rio de Janeiro
Rio de Janeiro, 21941-290, Brazil
Universidade Federal da Bahia - Hospital
Salvador, 40110-060, Brazil
Hospital Sao Paulo
São Paulo, 01244-020, Brazil
Hospital Israelita Albert Einstein
São Paulo, 05651-901, Brazil
University of Calgary
Calgary, Alberta, T2N 4NI, Canada
Toronto Digestive Disease Associates, Inc.
Toronto, Ontario, M3N2V7, Canada
Hopital Maisonneuve-Rosemont
Montreal, Quebec, H1T2M4, Canada
Hópital Hótel-Dieu de Quebec
Québec, Quebec, G1R 2J6, Canada
GI Research
Edmonton, T5H4B9, Canada
Hospital del Salvador
Santiago, 7500922, Chile
Clinica Las Condes
Santiago, 7591046, Chile
Hospital Clinico P.UC
Santiago, 8330024, Chile
Hospital San Juan de Dios
Santiago, 8350533, Chile
Fakultni Nemocnice Plzen
Pilsen, 30460, Czechia
NZZ Online 24 s.r.o
Prague, 120 00, Czechia
Remedis s.r.o
Prague, 140 00, Czechia
Thomavers Hospital
Prague, 14059, Czechia
Klinicke Centrum ISCARE I.V.F
Prague, 170 04, Czechia
Nemocnice Jablonec nad Nisou p.o
Prague, 466 60, Czechia
Oblastni Nemocnice Pribram
Příbram, 261 26, Czechia
Nemocnice Tabor A.S.
Tábor, 390 03, Czechia
Masarykova Nemocnice
Ústí nad Labem, 401 13, Czechia
Bispebjerg Hospital
Copenhagen NV, 1400, Denmark
Hvidovre Hospital
Hvidovre, 2650, Denmark
Koge University Hospital
Køge, 4600, Denmark
CHU de Grenoble
Grenoble, France
Hospital De L'Archet
Nice, France
Hospital Haut Leveque
Pessac, France
Universitatsklinikum Freiburg
Freiburg im Breisgau, Germany
Universitat des Saarlandes
Homburg, Germany
Gastroenterologische Praxis Prof. Hackelsberger
Wiesbaden, Germany
Peterfy Sandor utcai
Budapest, H-1076, Hungary
Semmelweis Egyetem
Budapest, H-1083, Hungary
Debreceni Egyetem OEC - III
Debrecen, H-4012, Hungary
Markhot Ferenc Korhaz-Rendelointeze II. Belgyogyaszat - Gasztroenterologia
Eger, H-3300, Hungary
Pandy Kalman County Hospital
Gyula, H-5700, Hungary
Amrita Institute of Medical Sciences
Kochi, Kerala, 682 026, India
Lifeline Multispeciality Hospital
Chennai, 600096, India
Asian Institute of Gastreoenterology
Hyderabaad, 500082, India
S.R. Kalla Memorial Gastro & General Hospital
Jaipur, 302001, India
Sanjay Gandhi Post Graduate Institute of Medical Sciences
Lucknow, 226 014, India
Dayanand Medical College and Hospital
Ludhiana, 141 001, India
Jaslok Hospital and Research Centre
Mumbai, 400 026, India
All India Institute of Medical Sciences
New Delhi, 110 029, India
Sree Gokulam Medical Centre & Research Foundation
Trivandrum, 695607, India
Unidad Medica de Endoscopia y Cirugia (UNIMEDEC)
La Paz, Baja California Sur, CP23000, Mexico
Hospital San Javier
Guadalajara, 44670, Mexico
Central de Especialidades Medicas (FIDEPAZ)
La Paz, 23090, Mexico
Mexican Institute of Clinical Research
Mexico City, 6700, Mexico
Instituto Nacional de Ciencias médicas y Nutrición Salvador Zubirán
Mexico City, CP 14000, Mexico
Hospital Angeles Torreón
Torreón, 27250, Mexico
Orbis Medical Centre
Sittard, 6162 BG, Netherlands
Isala Clinics
Zwolle, 8025 AB, Netherlands
Shakespeare Specialist Group
Auckland, 620, New Zealand
Waikato DHB Hospital
Hamilton, 2001, New Zealand
Tauranga Hospital BOP Medical
Tauranga, 3112, New Zealand
Wellington Hospital
Wellington, 6242, New Zealand
Hospital Nacional Edgardo Rebagliati Martins
Lima, Lima-11, Peru
Hospital Nacional Guillermo Alemnara Irigoyen
Lima, Lima-13, Peru
Clinica Anglo America
Lima, Lima-27, Peru
Clinica El Golf
Lima, Lima-27, Peru
Klinika Gastroenterologi
Bialystok, Poland
Klinika Gastroenterologii
Lodz, Poland
Klinika Gastroenterologii
Szczecin, Poland
Miejska Przychodnia Specjalistyczna
Torun, Poland
Katedra i Klinika Gastroenterologii
Warsaw, Poland
Hospital Sao Marcos
Braga, 4701-965, Portugal
Hospital Egas Moniz
Lisbon, 1349-019, Portugal
Hospital Geral Santo Antonio
Porto, 4099-001, Portugal
Colentina Clinical Hospital
Bucharest, 020125, Romania
Prf. Dr D. Gerota Emergency Hospital
Bucharest, 021392, Romania
Octavian Fodor Clinical Emergency Hospital
Cluj-Napoca, 400162, Romania
County Emergency Hospital
Constanța, 900591, Romania
Institute of Gastronenterology & Hepatology
Iași, 700111, Romania
Clinical County Emergency Hospital
Târgu Mureş, 540103, Romania
City Hospital #24
Moscow, Russia
City Hospital #51
Moscow, Russia
Scientific Centre of Coloproctology
Moscow, Russia
City Hospital #122
Saint Petersburg, Russia
Russian Academy of Sciences
Saint Petersburg, Russia
Singapore General Hospital
Singapore, 169608, Singapore
Tan Tock Seng Hospital
Singapore, 308433, Singapore
Changi General Hospital
Singapore, 529889, Singapore
Louis Leipoldt Medical Centre
Bellville, Western Cape, 7505, South Africa
New Groote Schuur Hospital
Observatory, Western Cape, 7925, South Africa
Kingsbury Hospital
Cape Town, 7708, South Africa
St Augustine's Hospital
Durban, 4001, South Africa
Parklands Medical Centre
Durban, 4091, South Africa
Milpark Hospital
Johannesburg, 2193, South Africa
Greenacres Hospital
Port Elizabeth, 6057, South Africa
2H Arun Place
Somerset West, 7130, South Africa
Hallyam University, Sacred Heart Hospital
Anyang-si, 431-070, South Korea
Seoul National University Hospital
Seoul, 110-744, South Korea
Samsung Medical Centre
Seoul, 135-710, South Korea
The Catholic University of Korea Kangnam St Mary's Hospital
Seoul, 137-040, South Korea
Asan Medical Center
Seoul, South Korea
Yonsei University, College of Medicine
Seoul, South Korea
Hospital Universitario Germans Trias I Pujol
Badalona, 08916, Spain
Hospital Universitario Reina Sofia
Córdoba, 14004, Spain
Hospital Universitario Ramon Y Cajal
Madrid, 28034, Spain
Hospital de Sagunto
Valencia, Spain
Sahlgrenska University Hospital
Gothenburg, 41345, Sweden
Sophiahemmet
Stockholm, 11486, Sweden
Karolinska University Hospital
Stockholm, 14186, Sweden
Karolinska University Hospital
Stockholm, 17176, Sweden
Taichung Veterans General Hospital
Taichung, 40705, Taiwan
National Taiwan University Hospital
Taipei, 10002, Taiwan
Taipei Veterans General Hospital
Taipei, 112, Taiwan
St. Mark's Hospital
Harrow, Middlesex, HA1 3UJ, United Kingdom
Addenbrookes Hospital Department of Gastroenterology
Cambridge, CB2 2QQ, United Kingdom
Imperial College School of Medicine
London, W12 0NN, United Kingdom
Royal Victoria Infirmary
Newcastle upon Tyne, NE1 4LP, United Kingdom
Royal Hallamshire Hospital
Sheffield, S10 2JF, United Kingdom
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Study Director
- Organization
- Shire
Study Officials
- STUDY DIRECTOR
Study Director
Takeda
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 7, 2005
First Posted
September 9, 2005
Study Start
April 8, 2005
Primary Completion
September 7, 2009
Study Completion
September 7, 2009
Last Updated
June 14, 2021
Results First Posted
September 21, 2010
Record last verified: 2021-06